BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28094268)

  • 1. Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival.
    Kang YJ; Balter B; Csizmadia E; Haas B; Sharma H; Bronson R; Yan CT
    Nat Commun; 2017 Jan; 8():14013. PubMed ID: 28094268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intracellular domain of L1CAM binds to casein kinase 2α and is neuroprotective via inhibition of the tumor suppressors PTEN and p53.
    Wang Y; Schachner M
    J Neurochem; 2015 Jun; 133(6):828-43. PubMed ID: 25727698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition.
    Dixit D; Sharma V; Ghosh S; Mehta VS; Sen E
    Cell Death Dis; 2012 Feb; 3(2):e271. PubMed ID: 22318540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase CK2 is required for the recruitment of 53BP1 to sites of DNA double-strand break induced by radiomimetic drugs.
    Guerra B; Iwabuchi K; Issinger OG
    Cancer Lett; 2014 Apr; 345(1):115-23. PubMed ID: 24333722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear PTEN interferes with binding of Ku70 at double-strand breaks through post-translational poly(ADP-ribosyl)ation.
    Guan J; Zhao Q; Mao W
    Biochim Biophys Acta; 2016 Dec; 1863(12):3106-3115. PubMed ID: 27741411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1.
    Gont A; Hanson JE; Lavictoire SJ; Parolin DA; Daneshmand M; Restall IJ; Soucie M; Nicholas G; Woulfe J; Kassam A; Da Silva VF; Lorimer IA
    Oncotarget; 2013 Aug; 4(8):1266-79. PubMed ID: 23907540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN Regulates Nonhomologous End Joining By Epigenetic Induction of NHEJ1/XLF.
    Sulkowski PL; Scanlon SE; Oeck S; Glazer PM
    Mol Cancer Res; 2018 Aug; 16(8):1241-1254. PubMed ID: 29739874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.
    Kim HS; Woolard K; Lai C; Bauer PO; Maric D; Song H; Li A; Kotliarova S; Zhang W; Fine HA
    Cancer Res; 2012 Nov; 72(22):6065-75. PubMed ID: 22986743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN and p53 are required for hypoxia induced expression of maspin in glioblastoma cells.
    Eitel JA; Bijangi-Vishehsaraei K; Saadatzadeh MR; Bhavsar JR; Murphy MP; Pollok KE; Mayo LD
    Cell Cycle; 2009 Mar; 8(6):896-901. PubMed ID: 19221500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition.
    Middleton FK; Patterson MJ; Elstob CJ; Fordham S; Herriott A; Wade MA; McCormick A; Edmondson R; May FE; Allan JM; Pollard JR; Curtin NJ
    Oncotarget; 2015 Oct; 6(32):32396-409. PubMed ID: 26486089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
    Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma.
    Sonabend AM; Carminucci AS; Amendolara B; Bansal M; Leung R; Lei L; Realubit R; Li H; Karan C; Yun J; Showers C; Rothcock R; O J; Califano A; Canoll P; Bruce JN
    Neuro Oncol; 2014 Sep; 16(9):1210-9. PubMed ID: 24637229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development.
    Kazantseva M; Eiholzer RA; Mehta S; Taha A; Bowie S; Roth I; Zhou J; Joruiz SM; Royds JA; Hung NA; Slatter TL; Braithwaite AW
    J Pathol; 2018 Sep; 246(1):77-88. PubMed ID: 29888503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain.
    Chow LM; Endersby R; Zhu X; Rankin S; Qu C; Zhang J; Broniscer A; Ellison DW; Baker SJ
    Cancer Cell; 2011 Mar; 19(3):305-16. PubMed ID: 21397855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of DNA-dependent protein kinase by protein kinase CK2 in human glioblastoma cells.
    Olsen BB; Issinger OG; Guerra B
    Oncogene; 2010 Nov; 29(45):6016-26. PubMed ID: 20711232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibitory effect of triple anti-tumor gene transfer using Semliki Forest virus vector in glioblastoma cells.
    Lee JS; Lee JH; Poo H; Kim MS; Lee SH; Sung MH; Kim CJ
    Int J Oncol; 2006 Mar; 28(3):649-54. PubMed ID: 16465369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.
    Batista LF; Roos WP; Christmann M; Menck CF; Kaina B
    Cancer Res; 2007 Dec; 67(24):11886-95. PubMed ID: 18089819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival.
    Barata JT
    Adv Enzyme Regul; 2011; 51(1):37-49. PubMed ID: 21035501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.